Pulmonary emphysema and lung cancer patients should seriously consider surgery to levy

Pulmonary emphysema and lung cancer patients should seriously consider surgery to levy

According to British scholar, after a second past the expected rate of ppoFEV1 <40% of patients with lung cancer usually do not advocate for surgical treatment, but the latest study found that the lung cancer patients with emphysema ppoFEV1 not accurately calculated, for their surgery Indications should be reconsidered. Leicester City Glenfield Hospital Dr. DA Waller and his colleagues on 29 patients with lung cancer in patients with lung emphysema after the effect was evaluated, of which 14 cases ppoFEV1 <40% (A), 15 cases ppoFEV1> 40% ( Group B). The results showed that, B group in Perioperative a significant reduction in FEV1, and no group A of the phenomenon. Although ppoFEV1 different, but the surgery in March after two FEV1 no significant difference. In addition, within 30 days after two people died in group A, while Group B did not. Nevertheless, the average survival time were similar. Moreover, the emphysema patients, with non-functional part of the lung tissue can sometimes improve their postoperative lung function. Therefore, the ppoFEV1 standard calculation method may have underestimated its value after the real FEV1. Dr. Waller noted that when the decision with emphysema patients with cancer of the lung cancer resection, surgery should be considered due to lung volume reduction of its impact. He suggested that the clinical ppoFEV1 for 40 percent of the surgical critical point should not continue to apply to such patients.